Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
668
datasets available to search
ShareScore release 0.9.0
Dataset results
668 results for “Everolimus”
Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations
ClinicalTrials.gov study NCT03352427. IPD Sharing: NO. Countries: 1. Publications: 1.
Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00886691. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov study NCT01062399. IPD Sharing: Not stated. Countries: 3. Publications: 2.
SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance
ClinicalTrials.gov study NCT01266148. IPD Sharing: Not stated. Countries: 3. Publications: 6.
Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
ClinicalTrials.gov study NCT00570921. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
ClinicalTrials.gov study NCT03659136. IPD Sharing: NO. Countries: 11. Publications: 2.
NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer
ClinicalTrials.gov study NCT01931163. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
ClinicalTrials.gov study NCT03245151. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
ClinicalTrials.gov study NCT00323739. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
ClinicalTrials.gov study NCT03839940. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targe
ClinicalTrials.gov study NCT01136733. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors
ClinicalTrials.gov study NCT01628913. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT01014351. IPD Sharing: Not stated. Countries: 1. Publications: 1.
EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions
ClinicalTrials.gov study NCT01435031. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T
ClinicalTrials.gov study NCT02332902. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)
ClinicalTrials.gov study NCT03163667. IPD Sharing: NO. Countries: 1. Publications: 2.
Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor
ClinicalTrials.gov study NCT00412061. IPD Sharing: Not stated. Countries: 15. Publications: 3.
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
ClinicalTrials.gov study NCT01642186. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus Versus Placebo in Head and Neck Cancer
ClinicalTrials.gov study NCT01111058. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial
ClinicalTrials.gov study NCT01035450. IPD Sharing: Not stated. Countries: 1. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.